RELATIONSHIP BETWEEN ANXIETY, BELIEFS ABOUT MEDICATION AND MEDICATION ADHERENCE IN PATIENTS WITH CARDIOVASCULAR DISEASE
DOI:
https://doi.org/10.58043/rphrc.128Keywords:
Medication Adherence, Anxiety, Beliefs About Medicines, Cardiovascular DiseasesAbstract
Introduction: Cardiovascular diseases are a group of pathologies quite prevalent in the Portuguese community. Anxiety disorders, medication adherence and beliefs about medicines are recognized risk factors that affect the control of cardiovascular diseases, and it is therefore important to be evaluated when monitoring these patients.Objectives: This study aimed to identify the existing tools to measure adherence to antihypertensive therapy, medication beliefs and anxiety disorders, validated for the Portuguese population.
Materials and methods: A literature review on the existing questionnaires was carried out to assess these three dimensions. The psychometric properties of each questionnaire were evaluated. Then, a selection was made of which tool is the most suitable for each one of the three parameters.
Results: With the research conducted, it was possible to find 5 questionnaires to measure adherence to therapy (HBCS, MUAH, MUAH-16, MAT and MMAS-8), 2 questionnaires to measure beliefs about medication (BMQ-Specific and B-IPQ) and 4 questionnaires to measure anxiety disorders (BAI, HADS-A, SHAI and STAI) in Portuguese patients. Conclusion: The HBCS, BMQ-Specific and BAI questionnaires were identified as useful tools in clinical practice, easy to apply and without additional costs. In this way, we hope to contribute to a better identification of patients at risk, so that more individualized and more effective intervention strategies are defined in improving the control of cardiovascular diseases.
Downloads
References
World Health Organization. Cardiovascular Diseases (CVDs). https://www.who.int/news-room/fact-sheets/ detail/cardiovascular-diseases-(cvds). Published 2017. Accessed January 27, 2020.
McGraw Hill. Medicina Interna de Harrison. 18th ed.; 2013.
Almeida JM, Xavier M, Cardoso G, et al. Estudo Epidemiológico Nacional de Saúde Mental. Lisboa: Faculdade de Ciências Médicas, Universidade Nova de Lisboa; 2013.
Barnhill JW. Considerações gerais sobre transtornos de ansiedade. Manual MSD. https://www.msdmanuals. com/pt-pt/casa/distúrbios-de-saúde-mental/ansiedade-e-transtornos-relacionados-ao-estresse/considerações-gerais-sobre-transtornos-de-ansiedade#. Accessed September 23, 2019.
Harvard Medical School. Anxiety and heart disease: A complex connection. Harvard Heal Publ. 2017:3-5. https://www.health.harvard.edu/heart-health/anxiety-and-heart-disease-a-complex-connection.
Batelaan NM, Seldenrijk A, Bot M, Van Balkom AJLM, Penninx BWJH. Anxiety and new onset of cardiovascular disease: Critical review and meta-analysis. Br J Psychiatry. 2016;208(3):223-231. doi:10.1192/bjp. bp.114.156554
Burnier M, Egan BM. Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management. Circ Res. 2019;124(7):1124-1140. doi:10.1161/CIRCRESAHA.118.313220
Carvalho E. Métodos de avaliação da adesão à terapêutica medicamentosa. Univ DA BEIRA Inter Ciências da Saúde. 2015:153.
Leite SN, Vasconcellos M da PC. Adesão à terapêutica medicamentosa: elementos para a discussão de conceitos e pressupostos adotados na literatura. Cien Saude Colet. 2003;8(3):775-782. doi:10.1590/s1413-81232003000300011
Svensson S, Kjellgren KI, Ahlner J, Säljö R. Reasons for adherence with antihypertensive medication. Int J Cardiol. 2000;76(2-3):157-163. doi:10.1016/S0167-5273(00)00374-0
Gentil L, Vasiliadis HM, Préville M, Bossé C, Berbiche D. Association between depressive and anxiety disorders and adherence to antihypertensive medication in community-living elderly adults. J Am Geriatr Soc. 2012;60(12):2297-2301. doi:10.1111/j.1532-5415.2012.04239.x
Chatziefstratiou A, Giakoumidakis K, Fotos N V. Scales for assessing medication adherence in patients with hypertension. Br J Nurs. 2019;28(21).
Müller S, Kohlmann T, Wilke T. Validation of the Adherence Barriers Questionnaire – an instrument for identifying potential risk factors associated with medication-related non-adherence. BMC Health Serv Res. 2015. doi:10.1186/s12913-015-0809-0
González-bueno J, Calvo-cidoncha E, Sevilla-sánchez D. Traducción y adaptación transcultural al español del cuestionario ARMS para la medida de la adherencia en pacientes pluripatológicos. Atención Primaria. 2017;49(8):459-464. doi:10.1016/j. aprim.2016.11.008
Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and Evaluation of the Adherence to Refills and Medications Scale ( ARMS ) among Low-Literacy Patients with Chronic Disease. Value Heal. 2009;12(1):118-123. doi:10.1111/j.1524-4733.2008.00400.x
Nguyen T, Caze A La, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol. 2012. doi:10.1111/bcp.12194
Pareja E, Elisabeth M, Prados E, Martínez F, José M, Corpas PG. Questionnaires on adherence to antihypertensive treatment : a systematic review of published questionnaires and their psychometric properties. Int J Clin Pharm. 2020;(0123456789). doi:10.1007/s11096-020-00981-x
Culig J, Leppée M. From Morisky to Hill-Bone ; Self-Reports Scales for Measuring Adherence to Medication. 2014;38:55-62.
Ranasinghe P, Jayawardena R, Katulanda P, Constantine GR, Ramanayake V, Galappatthy P. Translation and Validation of the Sinhalese Version of the Brief Medication Questionnaire in Patients with Diabetes Mellitus. J Diabetes Res. 2018;2018. doi:10.1155/2018/7519462
Song Y, Han H, Song H, Nam S, Nguyen T, Kim MT. Psychometric Evaluation of Hill-Bone Medication Adherence Subscale. Asian Nurs Res (Korean Soc Nurs Sci). 2011;5(3):183-188. doi:10.1016/j.anr.2011.09.007
Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc. 2013:90-94. doi:10.1331/ JAPhA.2011.09154
Nogueira-Silva L, Sá-Sousa A, Lima MJ, Monteiro A, Dennison-Himmelfarb C, Fonseca JA. Translation and cultural adaptation of the Hill-Bone Compliance to High Blood Pressure Therapy Scale to Portuguese. Rev Port Cardiol. 2016;35(2).
Weinman J, Graham S, Canfield M, et al. The Intentional Non-Adherence Scale (INAS): Initial development and validation. J Psychosom Res. 2018;115(August):110-116. doi:10.1016/j. jpsychores.2018.10.010
Zidan A, Awaisu A, Hasan S, Kheir N. The Living with Medicines Questionnaire :Translation and Cultural Adaptation into the Arabic Context. Value Heal Reg Issues. 2016;10:36-40. doi:10.1016/j.vhri.2016.07.001
Cabral AC, Castel-Branco M, Caramona M, Fernandez-Llimos F, Figueiredo I V. Developing an adherence in hypertension questionnaire short version: MUAH-16. J Clin Hypertens. 2018;20(1):118-124. doi:10.1111/jch.13137
Wetzels G, Nelemans P, Wijk B Van, Broers N, Schouten J, Prins M. Determinants of poor adherence in hypertensive patients: Development and validation of the ‘“Maastricht Utrecht Adherence in Hypertension (MUAH) -questionnaire.”’ 2006;64:151-158.
Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42:241-247.
Sowunmi O, Onifade P. Psychometric Evaluation of Medication Adherence Rating Scale (MARS) among Nigerian Patients with Schizophrenia. Niger J Clin Pract. 2019:1281-1285. doi:10.4103/njcp.njcp
Vanelli I, Chendo I, Gois C, Santos J, Levy P. Adaptação e Validação da Versão Portuguesa da Escala de Adesão à Terpêutica. Acta Med Port. 2011:2009-2012.
Unni EJ, Olson JL, Farris KB. Revision and validation of Medication Adherence Reasons Scale (MAR-Scale). Curr Med Res Opin. 2014;30(2):211-221. doi:10.1185/0 3007995.2013.851075
Scribano ML, Caprioli F, Michielan A, et al. Translation and initial validation of the Medication Adherence Report Scale (MARS) in Italian patients with Crohn’s disease. Dig Liver Diseas. 2019;51:640-647. doi:10.1016/j.dld.2018.09.026
Tommelein E, Mehuys E, Tongelen I Van, Brusselle G, Boussery K. Accuracy of the Medication Adherence Report Scale (MARS-5) as a Quantitative Measure of Adherence to Inhalation Medication in Patients With COPD. Ann Pharmacother. 2014. doi:10.1177/1060028014522982
Sampaio R, Dias CC, Horne R, Lopes JMC. Portuguese version of the Medication Adherence Report Scale (MARS‐9): Validation in a population of chronic pain patients. J Eval Clin Pract. 2019;(December 2018):346-352. doi:10.1111/jep.13098
Ueno H, Yamazaki Y, Yonekura Y, Park MJ, Ishikawa H, Kiuchi T. Reliability and validity of a 12-item medication adherence scale for patients with chronic disease in Japan. BMC Health Serv Res. 2018:1-9.
NguyenT,CazeALa,CottrellN.Validatedadherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial. BMJ. 2016:1-10. doi:10.1136/bmjopen-2016-013375
Toll BA, McKee SA, Martin DJ, Jatlow P, O’Malley SS. Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. NIH. 2008;9(5):597-605. doi:10.1080/14622200701239662.Factor
Zweben A, Piepmeier ME, Fucito L, Malley SSO, Haven N. The Clinical Utility of the Medication Adherence Questionnaire (Maq) in an Alcohol PharmacotherapyTrial.HHS.2018:72-78.doi:10.1016/j. jsat.2017.04.001.The
Jankowska-pola B, Blicharska K, Uchmanowicz I, Morisky DE. The influence of illness acceptance on the adherence to pharmacological and non-pharmacological therapy in patients with hypertension. Eur J Cardiovasc Nurs. 2016. doi:10.1177/1474515115626878
Moharamzad Y, Saadat H, Shahraki BN, Rai A, Saadat Z. Validation of the Persian Version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients. Glob J Health Sci. 2015;7(4):173-183. doi:10.5539/gjhs.v7n4p173
Arnet I, Metaxas C, Walter PN, Morisky DE, Scm S, Hersberger KE. The 8-item Morisky Medication Adherence Scale translated in German and validated against objective and subjective polypharmacy adherence measures in cardiovascular patients. J Eval Clin Pract. 2015;21:271-277. doi:10.1111/jep.12303
Jankowska-Polanska B, Uchmanowicz I, Chudiak A, Dudek K, Morisky DE, Szymanska-Chabowska A. Psychometric properties of the Polish version of the eight-item Morisky Medication Adherence Scale in hypertensive adults. Dove Press J Patient Prefer Adherence. 2016:1759-1766.
Gallagher BD, Muntner P, Moise N, et al. Are two commonly used self-report questionnaires useful for identifying antihypertensive medication non-adherence? HHS. 2016;33(March 2013):1108-1113. doi:10.1097/ HJH.0000000000000503.Are
Cabral AC, Moura-ramos M, Castel-branco M, Fernandez-llimos F, Figueiredo I V. Cross-cultural adaptation and validation of a European Portuguese version of the 8-item Morisky medication. Rev Port Cardiol. 2018;37(4):297-303. doi:10.1016/j. repc.2017.09.017
Amaral O, Chaves C, Duarte J, Coutinho E, Nelas P. Treatment adherence in hypertensive patients - a cross-sectional study. Procedia - Soc Behav Sci. 2015;171:1288-1295.doi:10.1016/j.sbspro.2015.01.243
Delgado A, Lima ML. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psicol SAÚDE DOENÇAS. 2001;2(2):81-100.
Rodrigues A, Aparecida R, Dantas S. Adaptação e validação de uma medida de adesão à terapia de anticoagulação oral. Rev Lat Am Enfermagem. 2010;18(3):3-10.
Cabral AC, Moura-ramos M, Castel-Branco M, Caramona M, Fernandez-Llimos F, Figueiredo I V. Influence of the mode of administration on the results of medication adherence questionnaires. J Eval Clin Pract. 2017;(November 2016):1252-1257. doi:10.1111/ jep.12773
Kelly MS, Moczygemba LR, Gatewood SS. Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report Medication Adherence Scale. J Pharm Pract. 2016;29(3):194-198. doi:10.1177/0897190014550003
Garzón NE, Patricia L. Validity and Reliability of the Treatment Adherence Questionnaire for Patients with Hypertention. Investig y Educ en Enfermería. 2019;37. doi:10.17533/udea.iee.v37n3e09.Vol.
Bennett SJ, Milgrom LB, Champion V, Huster GA. Beliefs about medication and dietary compliance in people with heart failure: An instrument development study. Hear Lung. 1997;26(4).
Thomason MM, Poulopoulos N, Nguyen E, Gumidyala AP, Kahn SA, Greenley RN. Reliability and validity of the Beliefs About Medication Scale in pediatric inflammatory bowel disease. J Child Heal Care. 2017. doi:10.1177/1367493517712115
Horne R, Clatworthy J, Polmear A, Weinman J. Do hypertensive patients’ beliefs about their illness and treatment influence medication adherence and quality of life? J Hum Hypertens. 2001;15:S65-S68. doi:10.1038/sj.jhh.1001081
Mardby A-C, Akerlind I, Jorgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns. 2007;69:158-164. doi:10.1016/j.pec.2007.08.011
Jimenez K, Vargas C, Garcia K, Guzman H, Angulo M, Billimek J. Evaluating the Validity and Reliability of the Beliefs About Medicines Questionnaire in Low-Income, Spanish-Speaking Patients with Diabetes in the United States. Diabetes Educ. 2018;43(1):114-124. doi:10.1177/0145721716675740.Evaluating
Beck E-M,Vogelin R,Wirtz M,Cavelti M,Kvrgic S, Vauth R. Do Patients With Schizophrenia Distinguish Between Attitudes Toward Antipsychotic Medication and Pharmacotherapy in General? Validation of the Beliefs About Medication Questionnaire. J Nerv Ment Dis. 2012;200(1). doi:10.1097/ NMD.0b013e31823e5875
VerhagenAP.BeliefsaboutMedicineQuestionnaire. J Physiother. 2018;64(1):60. doi:10.1016/j. jphys.2017.04.006
Sweileh WM, Zyoud SH, Abu RJ, Deleq MI, Enaia MI. Influence of patients’ disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014:1-8.
Salgado T, Marques A, Geraldes L, Benrimoj S, Horne R, Fernandez-Llimos F. Adaptação transcultural do Beliefs about Medicines Questionnaire para o Português. Sao Paulo Med J. 2013;131(2):88-94. doi:10.1590/S1516-31802013000100018
Thorneloe RJ, Griffiths CEM, Ashcroft DM, Cordingley L. The challenges of assessing patients’ medication beliefs: a qualitative study. BMC Health Serv Res. 2017:1-11. doi:10.1186/s12913-017-2020-y
Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Br Soc Rheumatol. 2005:762-767. doi:10.1093/ rheumatology/keh587
Park HY, Seo SA, Yoo H, Lee K. Medication adherence and beliefs about medication in elderly patients living alone with chronic diseases. Dove Press J Patient Prefer Adherence. 2018:175-181.
ClyneB,CooperJA,BolandF,HughesCM,FaheyT, Smith SM. Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care. Br J Gen Pract. 2017;( July):507-518.
Hong SH. Potential for physician communication to build favorable medication beliefs among older adults with hypertension: A cross-sectional survey. PLoS One. 2019:1-12.
Koster ES, Heerdink ER, Vries TW de, Bouvy ML. Attitudes towards medication use in a general population of adolescents. Eur J Pediatr. 2014:483-488. doi:10.1007/s00431-013-2211-4
Wei L, Champman S, Li X, et al. Beliefs about medicines and non-adherence in patients with stroke , diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China. BMJ. 2017:1-8. doi:10.1136/ bmjopen-2017-017293
Emilsson M, Berndtsson I, Gustafsson PA, Horne R. Reliability and validation of Swedish translation of Beliefs about Medication Specific (BMQ-Specific) and Brief Illness Perception Questionnaire (B-IPQ) for use in adolescents with attention-deficit hyperactivity disorder. Nord J Psychiatry. 2020;74(2):89-95. doi:10.108 0/08039488.2019.1674376
Noumani H Al, Wu J-R, Barksdale D, Knafl G, Alkhasawneh E, Sherwood G. Health Beliefs and Medication Adherence in Omanis with Hypertension. HHS - J Cardiovasc Nurs. 2019;33(6):518-526. doi:10.1097/JCN.0000000000000511.Health
Kale MS, Federman AD, Krauskopf K, et al. The Association of Health Literacy with Illness and Medication Beliefs among Patients with Chronic Obstructive Pulmonary Disease. PLoS One. 2015:1-10. doi:10.1371/journal.pone.0123937
Krauskopf K, Federman AD, Kale MS, et al. Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication Adherence. HHS - COPD. 2016;12(2):151-164. doi:10.3109/15412 555.2014.922067.Chronic
Sjölander M, Eriksson M, Glader E. The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectiona questionnaire survey. BMJ. 2013:1-8. doi:10.1136/ bmjopen-2013-003551
Horne R, Faasse K, Cooper V, et al. The perceived sensitivity to medicines (PSM) scale: An evaluation of validity and reliability. Br J Health Psychol. 2013:18-30. doi:10.1111/j.2044-8287.2012.02071.x
Dolder CR, Lacro JP, Warren KA. Brief Evaluation of Medication Influences and Beliefs: Development and TestingofaBriefScaleforMedicationAdherence.JClin Psychopharmacol. 2004;24(4):404-409. doi:10.1097/01. jcp.0000130554.63254.3a
Eakin MN, Chung S-E, Hoehn J, Borrelli B, Rand-GiovannettiD,RiekertKA.DevelopmentandValidation of CF-Medication Beliefs Questionnaire: A mixed-methods approach. HHS - J Cyst Fibros. 2018;16(5):637-644. doi:10.1016/j.jcf.2017.05.001.Development
Machado V, Alves R, Ramos C, Proença L, Cavacas MA. Psychometric properties of the Brief Illness Perception Questionnaire (Brief ‐ IPQ) in periodontal diseases. J Clin Periodontol. 2019;(May):1183-1191. doi:10.1111/jcpe.13186
Foley KA, Vasey J, Berra K, Alexander CM, Markson LE. The Hyperlipidemia: Attitudes and Beliefs in Treatment (HABIT) Survey for Patients Results of a Validation Study. J Cardiovasc Nurs. 2005;20(1):35-42.
Zebb BJ,Moore MC.Another look at the psychometric properties of the Anxiety Control Questionnaire. Behav Res Therepy. 1999;37.
OlthuisJV,WattMC,StewartSH.AnxietySensitivity Index (ASI-3) subscales predict unique variance in anxiety and depressive symptoms. J Anxiety Disord. 2014;28(2):115-124. doi:10.1016/j.janxdis.2013.04.009
ZvolenskyMJ,GareyL,FergusTA,etal.Refinementof Anxiety Sensitivity Measurement:The Short Scale Anxiety SensitivityIndex(SSASI).PsychiatryRes.2019;(713):549-557. doi:10.1016/j.psychres.2018.08.115.Refinement
Julian LJ. Measures of Anxiety. Arthritis Care Res. 2011;63:467-472. doi:10.1002/acr.20561.Measures
Aaron T. Beck, Gary Brown, Kiyosaki RT, Lechter SL. An Inventory for Measuring Clinical Anxiety: Psychometric Properties. J Consult Clin Psychol. 1988;56(6):893-897. http://citeseerx.ist.psu.edu/ viewdoc/download?doi=10.1.1.471.4319&rep=rep1&typ e=pdf%0Ahttps://pdfs.semanticscholar.org/1a3e/334f16 b6888843a8150ddf7e4f46b2b28fd5.pdf.
De Lima Osório F, Crippa JAS, Loureiro SR. Further psychometric study of the Beck Anxiety Inventory including factorial analysis and social anxiety disorder screening. Int J Psychiatry Clin Pract. 2011;15(4):255-262. doi:10.3109/13651501.2011.605955
Lee K, Kim D, Cho Y. Exploratory Factor Analysis of the Beck Anxiety Inventory and the Beck Depression Inventory-II in a Psychiatric Outpatient Population. JKMS.2018;33(16):1-11.
Oei TPS, Sawang S, Goh YW, Mukhtar F. Using the Depression Anxiety Stress Scale 21 (DASS-21) across cultures. Int J Psychol. 2013;48(6):6. doi:10.1080/002075 94.2012.755535
Weiss BJ, Calleo J, Rhoades HM, et al. The Utility Of The Generalized Anxiety Disorder Severity Scale (GADSS) With Older Adults In Primary Care. NIH - Depress Anxiety. 2009;26(1):1-13. doi:10.1002/da.20520. THE
Segal DL, June A, Payne M, Coolidge FL, Yochim B. Development and initial validation of a self-report assessment tool for anxiety among older adults: The Geriatric Anxiety Scale.J Anxiety Disord.2010;24(7):709-714. doi:10.1016/j.janxdis.2010.05.002
Massena PN, Araújo NB De, Pachana N, Laks J, Pádua AC De. Validation of the Brazilian Portuguese Version of Geriatric Anxiety Inventory – GAI-BR. Int Psychogeriatrics. 2014:1-7. doi:10.1017/ S1041610214001021
Gomez R,Summers M,Summers A,Wolf A,Summers J. Depression Anxiety Stress Scales-21: Measurement and Structural Invariance Across Ratings of Men and Women. 2014. doi:10.1177/1073191113514106
Covic T, Cumming SR, Pallant JF, et al. Depression and Anxiety in Patients with Rheumatoid Arthritis: Prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale ( DASS ) and the Hospital, Anxiety and Depression Scale ( HADS ). BMC Psychiatry. 2012;12(1):6. doi:10.1186/1471-244X-12-6
Zimmerman M, Martin J, Clark H, Mcgonigal P, Harris L, Holst CG. Measuring anxiety in depressed patients: A comparison of the Hamilton anxiety rating scale and the DSM-5 Anxious Distress Specifier Interview. J Psychiatr Res. 2017;93:59-63. doi:10.1016/j. jpsychires.2017.05.014
Belk RA, Pilling M, Rogers KD, Lovell K, Young A. The theoretical and practical determination of clinical cut-offs for the British Sign Language versions of PHQ-9 and GAD-7. BMC Psychiatry. 2016;(December 2011):1-12. doi:10.1186/s12888-016-1078-0
SchaletBD,CookKF,ChoSW,CellaD.Establishing a Common Metric for Self-Reported Anxiety: Linking the MASQ, PANAS, and GAD-7 to PROMIS Anxiety. J Anxiety Disord. 2015;28(1):88-96. doi:10.1016/j.janxdis.2013.11.006.Establishing
Ball SG, Lipsius S, Escobar R. Validation of the geriatric anxiety inventory in a duloxetine clinical trial for elderly adults with generalized anxiety disorder. Int Psychogeriatrics. 2015:1533-1539. doi:10.1017/ S1041610215000381
Rozzini R,Trabucchi M.Use of the Geriatric Anxiety Inventory – short form as a screening tool for detection of generalised anxiety in a memory clinic population. 2013;31:2012-2013. doi:10.1002/gps.3897
Mueller AE, Segal DL, Gavett B, et al. Geriatric Anxiety Scale : item response theory analysis, differential item functioning , and creation of a ten-item short form (GAS-10). Int Psychogeriatrics. 2014:1-13. doi:10.1017/ S1041610214000210
Thompson E. Hamilton Rating Scale for Anxiety (HAM-A). Occup Med (Chic Ill). 2015;(April):2015. doi:10.1093/occmed/kqv054
Correia DT, Barbosa A. Ansiedade e Depressão em Medicina: Modelos Teóricos e Avaliação. Acta Med Port. 2009:89-98.
Herrmann C. International Experiences With The Hospital Anxiety And Depression Scale - A Review Of Validation Data And Clinical Results. J Psychosom Res. 1997;42.
Beekman E, Verhagen A. Clinimetrics: Hospital Anxiety and Depression Scale. J Physiother. 2018;64(3):198. doi:10.1016/j.jphys.2018.04.003
Stern AF. The Hospital Anxiety and Depression Scale. Occup Med (Chic Ill). 2014:393-394. doi:10.1093/ occmed/kqu024
Sousa C, Pereira MG. Morbilidade psicológica e representações da doença em pacientes com esclerose múltipla: Estudo de validação da “Hospital Anxiety and Depression Scale” (HADS). Psicolofia, Saúde & Doenças. 2008;9(2):283-298.
Beard C, Rodriguez BF, Moitra E, Sibrava NJ, Weisberg RB, Keller MB. Psychometric Properties of the Liebowitz Social Anxiety Scale (LSAS) in a Longitudinal Study of African Americans with Anxiety Disorders. J Anxiety Disord. 2012;25(5):722-726. doi:10.1016/j.janxdis.2011.03.009.Psychometric
Glischinski M von, Willutzki U, Stangie U, et al. Liebowitz Social Anxiety Scale (LSAS): Optimal cut points for remission and response in a German sample. Clin Psychol Psychother. 2018;( January):465-473. doi:10.1002/cpp.2179
Wardenaar KJ, Veen T Van, Giltay EJ, Beurs E De, Penninx BWJH, Zitman FG. Development and validation of a 30-item short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ). Psychiatry Res. 2010;179(1):101-106. doi:10.1016/j. psychres.2009.03.005
Buckby JA, Yung AR, Cosgrave EM, Cotton SM. Distinguishing between anxiety and depression using the Mood and Anxiety Symptoms Questionnaire (MASQ). Br J Clin Psychol. 2007:235-239. doi:10.1348/014466506X132912
Thaler NS, Kazemi E, Wood JJ. Measuring Anxiety in Youth with Learning Disabilities : Reliability and Validity of the Multidimensional Anxiety Scale for Children(MASC).ChildPsychiatryHumDev.2010:501- 514. doi:10.1007/s10578-010-0182-5
Ólason DT, Sighvatsson MB, Smári J, Masc C. Psychometric properties of the Multidimensional Anxiety Scale for Children (MASC) among Icelandic schoolchildren. Scand J Psychol. 2004;(Cdi):429-436.
March JS, Sullivan K. Test-Retest Reliability of the Multidimensional Anxiety Scale for Children. J Anxiety Disord. 1999;13(4):349-358.
Piqueras JA, Martín-vivar M, Sandin B, San C, Pineda D. The Revised Child Anxiety and Depression Scale: A systematic review and reliability generalization meta-analysis. J Affect Disord. 2017;218(December 2016):153-169. doi:10.1016/j.jad.2017.04.022
Morales A,Reis S,Espada JP,Orgilés M.Portuguese validation of the Short Health Anxiety Inventory: Factor structure , reliability, and factor invariance. J Health Psychol. 2018. doi:10.1177/1359105316669859
Ranta K, Junttila N, Laakkonen E, Uhmavaara A, Greca AM La. Social Anxiety Scale for Adolescents (SAS-S): Measuring Social Anxiety Among Finnish Adolescents. Child Psychiatry Hum Dev. 2012:574-591. doi:10.1007/s10578-012-0285-2
Pechorro P, Ayala-Nunes L, Nunes C, Marôco J, Gonçalves RA. The Social Anxiety Scale for Adolescents: Measurement Invariance and Psychometric Properties Among a School Sample of Portuguese Youths. Child Psychiatry Hum Dev. 2016;47(6):975-984. doi:10.1007/s10578-016-0627-6
Heidenreich T, Schermelleh-Engel K, Schramm E, Hofmann SG, Stangier U. The factor structure of the Social Interaction Anxiety Scale and the Social Phobia Scale. J Anxiety Disord. 2011;25(4):579-583. doi:10.1016/j.janxdis.2011.01.006
Orgilés M, Méndez X, Spence SH, Huedo-Medina TB, Espada JP. Spanish Validation of the Spence Children’s Anxiety. Child Psychiatry Hum Dev. 2012:271-281. doi:10.1007/s10578-011-0265-y
Whiteside SP, Brown AM. Exploring the utility of the Spence Children’s Anxiety Scales parent-and child-report forms in a North American sample. J Anxiety Disord. 2008;22:1440-1446. doi:10.1016/j. janxdis.2008.02.006
Orgilés M, Penosa P, Fernández‐Martínez I, Marzo JC, Espada JP. Spanish validation of the Spence Preschool Anxiety Scale. 2018;(October 2017):753-758. doi:10.1111/cch.12593
Fernández-Blázqueza MA, Ávila-Villanueva M, López-Pina JA, Frades-Payo B, Zea-Sevilla MA. Propiedades psicométricas de una nueva versión abreviada del State-Trait Anxiety Inventory (STAI) para valorar el nivel de ansiedad en personas mayores. Neurología. 2015;30(6):352-358.
Andrade L, Gorenstein C, Vieira Filho AH, Tung TC, Artes R. Psychometric properties of the Portuguese version of STAI Brazilian. J Med Biol Res. 2001;34(3):367-374.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Raquel Coelho, Maria Teresa Herdeiro, Isabel Vitória Figueiredo, Ana C. Cabral
This work is licensed under a Creative Commons Attribution 4.0 International License.
